B. Kaden

Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248

R. Advani, S. Treon, Z. Hunter, 2007, Clinical Cancer Research.

Multicenter ClinicalTrial of Bortezomib in Relapsed / Refractory Waldenstrom ’ s Macroglobulinemia : Results of WMCTGTrial 03-248

R. Advani, S. Treon, Z. Hunter, 2007 .

Bing–Neel syndrome: an illustrative case and a comprehensive review of the published literature

J. Raizer, M. Tallman, R. Malkani, 2010, Journal of Neuro-Oncology.

Immune thrombocytopenia in lymphoproliferative diseases.

W. Rosse, B. Kaden, T. Hauch, 1979, Blood.

Phase II Study of Bortezomib in Waldenstrom’s Macroglobulinemia: Results of WMCTG Trial 03-248.

R. Advani, S. Treon, Z. Hunter, 2005 .

Inhibition of Acetylcholinesterase Activity in Human Brain Tissue and Erythrocytes by Galanthamine, Physostigmine and Tacrine

H. Barz, T. Thomsen, U. Bickel, 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.